Fixnip

Hypodermic Nipple Implants

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in May 2015 by Yagil Netta and Daniel Korkos, Fixnip operates with 1-10 employees. The company has secured funding across one round from one investor. In May 2022, GC Aesthetics announced the launch of FixNip, highlighting its impact on breast reconstruction.

Business overview

Fixnip is a medical device startup specializing in hypodermic silicone nipple implants. The company's solution, which combines laser cutting, cast molding, and clean room technology with advanced materials like Nitinol and soft medical silicone, aims to restore self-confidence for women undergoing post-mastectomy breast reconstruction, inverted nipple repair, or aesthetic enhancement. The product maintains mechanical strength and a natural feel, requiring a minimally invasive outpatient procedure. Fixnip operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Pharma & Medical Biotechnology industries.

Strategic signal

In May 2022, GC Aesthetics announced the launch of FixNip, positioning it as a significant advancement in breast reconstruction. This signals strong market validation and potential for widespread adoption of Fixnip's innovative implant technology, indicating a growth-positive trajectory for the company within the medical aesthetics and reconstructive surgery markets.

Log in to access full profile

Company Intelligence Q&A

What is Fixnip's core product?
Fixnip develops hypodermic silicone nipple implants designed for post-mastectomy breast reconstruction, inverted nipple repair, and aesthetic nipple enhancement. The product uses a patented Nitinol skeleton combined with soft medical silicone for a natural feel and consistent structure.
When was Fixnip founded and by whom?
Fixnip was founded in May 2015 by Yagil Netta and Daniel Korkos.
What was a significant product launch for Fixnip?
In May 2022, GC Aesthetics announced the launch of FixNip, highlighting its potential as a game-changer in breast reconstruction.
What is the primary market Fixnip addresses?
Fixnip addresses the medical aesthetics and reconstructive surgery markets, providing solutions for women seeking to regain self-confidence through nipple reconstruction or enhancement.
Log in to access full profile